News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
BIRMINGHAM, Ala., August 13, 2026--(BUSINESS WIRE)--MPT (the "Company" or "MPT") (NYSE: MPT) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.09 per share of common stock to be paid on October 8, 2026, to stockholders of record on …
Sharemaestro market context Price below Trend Line 52 weeks -4.8%An investor group led by Bleichroeder LP has disclosed a 6.23% beneficial ownership stake in Modular Medical, Inc. (MODD), totaling 336,986 common shares with sole voting and dispositive power. The group also holds warrants for an additional 110,092 shares, but their exercise is subject …
Wellington Management Group LLP and its related entities have reported a beneficial ownership of 7,673,983 shares of Dick's Sporting Goods, Inc. common stock, which accounts for 11.64% of the class. These shares are held for advisory clients, with shared voting power over 6,981,208 shares …
Vivani Medical (VANI) has reported a net loss of $6.4 million for Q2 2026 and $13.2 million for the first half of 2026, with cash and equivalents totaling $19.9 million, which is projected to fund operations into Q2 2027. The company is advancing its …
This article reports on the filing of a Form 8K by Vivani Medical Inc. on August 13th, as tracked by Investing.com. The brief mention indicates a financial disclosure event for the company, with the stock symbol VANI noted to have experienced a -2.19% change.
Vivani Medical reported its second-quarter 2026 financial results, highlighting significant progress in its clinical development, including the successful dosing of all participants in its SLIM-1 Phase 1 trial for NPM-139, a semaglutide implant for chronic weight management. The company also announced a non-exclusive agreement …
Vivani Medical (VANI) reported its Q2 2026 financial results, highlighting the successful dosing of all 20 participants in its Phase 1 SLIM-1™ trial for NPM-139, a semaglutide implant, with top-line data expected in November 2026. The company also announced a non-exclusive agreement with Novo …
Tenon Medical reported a significant revenue increase of 127% to $1.3 million in Q2 2026, driven by higher surgical procedures and the SImmetry®+ System, alongside an improved gross margin of 64%. Despite this growth, the company's net loss widened to $4.1 million, and it …
Tenon Medical (NASDAQ:TNON) announced its second quarter 2026 financial results, reporting a 127% increase in revenue to $1.3 million and a 232% increase in gross profit to $0.8 million compared to the prior year. The company also received FDA 510(k) clearance for its updated …
Generate Biomedicines (NASDAQ: GENB) utilizes machine learning and generative AI for novel therapeutic design and discovery. The company recently reported Q2 2026 earnings, missing analyst estimates, and has a "Moderate Buy" consensus rating with a price target of $25.40, suggesting a 62.4% upside. Its …
This article provides a comprehensive overview of DiaMedica Therapeutics Inc. (DMAC), including its current stock price, financial statistics, historical data, and analyst insights. It highlights DMAC as a clinical-stage biopharmaceutical company focused on ischemic diseases, with its lead candidate DM199 in Phase 2/3 trials. …
Janus Henderson Group Ltd. has reported a beneficial ownership of 2,781,621 shares of ICU Medical, Inc. common stock, which constitutes 11.1% of the class. These shares are held through various Managed Portfolios where Janus Henderson's affiliated Asset Managers exercise investment and voting discretion, though …
Janus Henderson Group Ltd. has disclosed a 5.1% beneficial ownership stake in Revolution Medicines, Inc. (RVMD), holding 10,736,145 shares of common stock. These shares are managed across various client portfolios, with Janus Henderson exercising shared voting and dispositive power but disclaiming economic ownership, which …
This article analyzes the volatility of Utah Medical Products Inc. (NASDAQ: UTMD), highlighting a strong overweight bias across all sentiment horizons. It details three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, providing entry and exit points, targets, …
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Marcio De'SouzaChief Financial Officer - Tim KellyPresident of Research and Development - Steve PetrouChief Operating Officer - Megan Sniecinski TAKEAWAYS Cash and …
Pediatrix Medical Group, Inc. MD is a physician services provider company that offers a range of services across various specialties, including obstetrics, maternal-fetal medicine and neonatology, complemented by multiple pediatric subspecialties. The company has gained 23.9% in the year-to-date period, outperforming the industry's 1.2% …
Sharemaestro market context Price below Trend Line 52 weeks +40.2% · Next-week setup negative 10.2%Credicorp, Peru's largest financial holding company, is set to report its second-quarter earnings, with analysts expecting moderate year-over-year gains in EPS and revenue but a sequential decline in EPS, indicating potential margin pressure. Investors will be keenly watching credit dynamics, net interest margins, and …
Fresenius Medical Care stock is trading near $24, with a slight decline of 0.67% on the NYSE and 0.28% in Europe, as investors analyze the company's latest capital market update. This update details recent share repurchases and trading activity, suggesting a strategy to optimize …
Argus has raised its target price for Merit Medical Systems Inc. (MMSI) to $100.00, citing the company's role as a medical equipment developer and manufacturer. The report, published on August 12, 2026, highlights MMSI's products for interventional cardiology, radiology, and endoscopy procedures. Full access …
Rockwell Medical (NASDAQ:RMTI) released its Q2 2026 results, showing 11% revenue growth and an 18% gross margin, despite narrowly missing Wall Street expectations. The company is advancing towards sustained profitability through operational improvements, customer diversification, and a strategic plan to exceed $100 million in …
SBC Medical Group Holdings reported mixed Q2 2026 results, exceeding revenue expectations with $49 million, a 13% year-on-year increase, but missing EPS forecasts at $0.10. The company highlighted a re-acceleration of growth following 2025 structural reforms, driven by clinic expansion, AI tool integration, and …
NeuroOne Medical Technologies reported a 16% year-over-year increase in Q3 2026 product revenue, reaching $2.0 million, driven by stronger sales of its OneRF brain ablation products and a 43% jump in orders. Despite revenue growth and improved gross margins, the company's net loss widened …
B. Riley Financial has reaffirmed its "Buy" rating for Journey Medical (NASDAQ:DERM), increasing its price target from $12 to $15, which suggests a 133.28% potential upside. Despite mixed analyst opinions, the company recently surpassed quarterly expectations, reporting an adjusted loss of $0.01 per share …
Rockwell Medical, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Operational Efficiency Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …
Rockwell Medical (RMTI) announced strong Q2 2026 results, with net sales increasing 11% year-over-year to $17.8 million and gross profit rising 30%. The company significantly narrowed its net loss to $1.2 million and generated positive operating cash flow of $2.1 million, strengthening its cash …
ICU Medical Inc's Chief Information Officer, Ben Sousa, sold 2,250 shares of the company's stock for approximately $401,220. This transaction contributes to a trend of insider selling at the company, with 9 sells versus 2 buys over the last year. The stock is currently …
Soleus Capital Master Fund, L.P. and affiliated entities have reported a 6.7% ownership stake in Inspire Medical Systems, Inc. (INSP), holding 1,931,436 shares of common stock. This beneficial ownership is based on 28,910,375 shares outstanding as of July 30, 2026, and grants shared voting …
SBC Medical Group Holdings Inc (NASDAQ:SBC) is expected to release its Q2 2026 earnings on August 13, 2026, with revenue projected at $45.45 million and earnings at $0.12 per share. For the full year 2026, revenue is estimated to be $180.98 million and earnings …
Search by ticker symbol or company name and select a result to open its chart.